Tratamiento con células madre en neonatos
Neonates are increasingly receiving more adequate care to ensure both their survival and their quality of life. Neonates can be treated with stem cells to treat serious lung diseases such as bronchopulmonary dysplasia (BPD). It is precisely the fragile newborns who have a higher percentage of risk o...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Spanish |
| Published: |
2022
|
| Subjects: | |
| Online Access: | https://dialnet.unirioja.es/servlet/oaiart?codigo=8448481 |
| Source: | RECIMUNDO: Revista Científica de la Investigación y el Conocimiento, ISSN 2588-073X, Vol. 6, Nº. 2, 2022, pags. 566-575 |
| Tags: |
Add Tag
No Tags: Be the first to tag this record
|
| id |
dialnet-ar-18-ART0001531015
|
|---|---|
| record_format |
dialnet
|
| institution |
Dialnet
|
| collection |
Dialnet AR
|
| source |
RECIMUNDO: Revista Científica de la Investigación y el Conocimiento, ISSN 2588-073X, Vol. 6, Nº. 2, 2022, pags. 566-575
|
| language |
Spanish
|
| topic |
Células Madre
Neonato Displasia Broncopulmonar (DBP) Fuentes de Extracción Celular Células Madre Stem Cells Neonate Bronchopulmonary Dysplasia (BPD) Cell Extraction Sources Stem Cells |
| spellingShingle |
Células Madre
Neonato Displasia Broncopulmonar (DBP) Fuentes de Extracción Celular Células Madre Stem Cells Neonate Bronchopulmonary Dysplasia (BPD) Cell Extraction Sources Stem Cells Rivera Mendoza, Gabriela Monserrate Rivera Mendoza, Viviana Vanessa Mera Macias, Juliana Monserrate Vallejo Figueroa, Rebeca Margarita Tratamiento con células madre en neonatos |
| description |
Neonates are increasingly receiving more adequate care to ensure both their survival and their quality of life. Neonates can be treated with stem cells to treat serious lung diseases such as bronchopulmonary dysplasia (BPD). It is precisely the fragile newborns who have a higher percentage of risk of developing it. Cell therapy strategies have been used for purposes as diverse as tissue regeneration, poten-tiation of the specific immune response for antitumor therapy, drug delivery in damaged tissues, and restoration of homeostasis in sites with chronic inflammatory processes. For this reason, the objective of this research is to make a compilation of the therapies in which stem cells are currently used in neonates, as well as those diseases in which this therapy is still under investigation with very promising results for its future application. . Likewise, evidence accumulated during the last decade will be collected, allowing the full potential that stem cells have in the treatment of newborns and other general applications to be assessed. The research was carried out under a bibliograph-ic documentary type methodology, under the review modality. Stem cell therapy in neonates is currently facing a lack of solid evidence to support its use, in terms of the efficacy and safety necessary for its therapeutic use. However, the advances in ongoing research are promising, in terms of proposing a treatment modality aimed at anatomically and functionally recovering tissues, organs and systems, which currently lead to chronic diseases. Therefore, more research is required in this regard. For these same reasons, it is recommended to adopt a conservative approach when offering this type of information to the parents of neonates
|
| format |
Article
|
| author |
Rivera Mendoza, Gabriela Monserrate
Rivera Mendoza, Viviana Vanessa Mera Macias, Juliana Monserrate Vallejo Figueroa, Rebeca Margarita |
| author_facet |
Rivera Mendoza, Gabriela Monserrate
Rivera Mendoza, Viviana Vanessa Mera Macias, Juliana Monserrate Vallejo Figueroa, Rebeca Margarita |
| author_sort |
Rivera Mendoza, Gabriela Monserrate
|
| title |
Tratamiento con células madre en neonatos
|
| title_short |
Tratamiento con células madre en neonatos
|
| title_full |
Tratamiento con células madre en neonatos
|
| title_fullStr |
Tratamiento con células madre en neonatos
|
| title_full_unstemmed |
Tratamiento con células madre en neonatos
|
| title_sort |
tratamiento con células madre en neonatos
|
| publishDate |
2022
|
| url |
https://dialnet.unirioja.es/servlet/oaiart?codigo=8448481
|
| _version_ |
1767464026984415232
|
| spelling |
dialnet-ar-18-ART00015310152023-05-30Tratamiento con células madre en neonatosRivera Mendoza, Gabriela MonserrateRivera Mendoza, Viviana VanessaMera Macias, Juliana MonserrateVallejo Figueroa, Rebeca MargaritaCélulas MadreNeonatoDisplasia Broncopulmonar (DBP)Fuentes de Extracción CelularCélulas MadreStem CellsNeonateBronchopulmonary Dysplasia (BPD)Cell Extraction SourcesStem CellsNeonates are increasingly receiving more adequate care to ensure both their survival and their quality of life. Neonates can be treated with stem cells to treat serious lung diseases such as bronchopulmonary dysplasia (BPD). It is precisely the fragile newborns who have a higher percentage of risk of developing it. Cell therapy strategies have been used for purposes as diverse as tissue regeneration, poten-tiation of the specific immune response for antitumor therapy, drug delivery in damaged tissues, and restoration of homeostasis in sites with chronic inflammatory processes. For this reason, the objective of this research is to make a compilation of the therapies in which stem cells are currently used in neonates, as well as those diseases in which this therapy is still under investigation with very promising results for its future application. . Likewise, evidence accumulated during the last decade will be collected, allowing the full potential that stem cells have in the treatment of newborns and other general applications to be assessed. The research was carried out under a bibliograph-ic documentary type methodology, under the review modality. Stem cell therapy in neonates is currently facing a lack of solid evidence to support its use, in terms of the efficacy and safety necessary for its therapeutic use. However, the advances in ongoing research are promising, in terms of proposing a treatment modality aimed at anatomically and functionally recovering tissues, organs and systems, which currently lead to chronic diseases. Therefore, more research is required in this regard. For these same reasons, it is recommended to adopt a conservative approach when offering this type of information to the parents of neonatesLos neonatos están recibiendo cada vez cuidados más adecuados para asegurar tanto su supervivencia como su calidad de vida. Los neonatos puedes recibir tratamiento con células madre para tratar enfermedades pulmonares de gran gravedad como lo es la displasia broncopulmonar (DBP). Precisamente son los frágiles recién nacidos quienes tienen un mayor porcentaje de riesgo de desarrollarla. Las estrategias de terapia celular se han utilizado con fines tan diversos como la regeneración de tejidos, la potenciación de la respuesta inmune antígeno específicas para la terapia antitumoral, la liberación de drogas en tejidos dañados y la restauración de la homeostasis en sitios con procesos inflamatorios crónicos. Por esta razón, el objetivo de la presente investigación es hacer un recopilatorio de las terapias en las que actualmente se emplean células madre en neonatos, así como aquellas enfermedades en las que esta terapia aún se encuentra en investigación con resultados muy prometedores para su futura aplicación. Asimismo, se recogen evidencias acumuladas durante la última década, permitiendo valorar todo el potencial que las células madre tienen en el tratamiento de recién nacidos y otras aplicaciones generales. La investigación se realizó bajo una metodología de tipo documental bibliográfica, bajo la modalidad de revisión. La terapia con células madre en neonatos, actualmente, se encuentra enfrentándose a la falta de evidencias sólidas que avalen su uso, en cuanto a una eficacia y seguridad necesaria para su utilización terapéutica. No obstante, los avances en la investigación en curso son prometedores, en cuanto a proponer una modalidad de tratamiento tendiente a recuperar anatómica y funcionalmente tejidos, órganos y sistemas, que en la actualidad conducen a enfermedades crónicas. Por consiguiente, se requiere más investigación al respecto. Por es-tas mismas razones, se recomienda adoptar una conducta conservadora al ofrecer este tipo de información a los padres de los neonatos2022text (article)application/pdfhttps://dialnet.unirioja.es/servlet/oaiart?codigo=8448481(Revista) ISSN 2588-073XRECIMUNDO: Revista Científica de la Investigación y el Conocimiento, ISSN 2588-073X, Vol. 6, Nº. 2, 2022, pags. 566-575spaLICENCIA DE USO: Los documentos a texto completo incluidos en Dialnet son de acceso libre y propiedad de sus autores y/o editores. Por tanto, cualquier acto de reproducción, distribución, comunicación pública y/o transformación total o parcial requiere el consentimiento expreso y escrito de aquéllos. Cualquier enlace al texto completo de estos documentos deberá hacerse a través de la URL oficial de éstos en Dialnet. Más información: https://dialnet.unirioja.es/info/derechosOAI | INTELLECTUAL PROPERTY RIGHTS STATEMENT: Full text documents hosted by Dialnet are protected by copyright and/or related rights. This digital object is accessible without charge, but its use is subject to the licensing conditions set by its authors or editors. Unless expressly stated otherwise in the licensing conditions, you are free to linking, browsing, printing and making a copy for your own personal purposes. All other acts of reproduction and communication to the public are subject to the licensing conditions expressed by editors and authors and require consent from them. Any link to this document should be made using its official URL in Dialnet. More info: https://dialnet.unirioja.es/info/derechosOAI
|